Laromustine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Laromustine, covering 2011-05-13 to 2019-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine [Phase 1, Phase 2]